Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

249
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomimetic Catalytic System Mimicking Immune Defense and Tissue Healing for Dynamic Treatment of Skin Infections.

Nano letters·2026
Same author

A Robust Strategy for Efficient Teeth Whitening and Oral Sterilization Leveraging the Synergistic Coupling of LSPR and Piezo-Phototronic Effects.

Advanced healthcare materials·2026
Same author

Biomaterial regulation of excessive inflammation restores osteoimmune homeostasis in diabetic bone regeneration.

Regenerative biomaterials·2026
Same author

Nanoconfinement Enabled High-Efficiency and Long-Lifetime Multicolor Afterglow Hydrogels for Advanced Spatiotemporal Encryption and Pathogen Eradication.

Angewandte Chemie (International ed. in English)·2026
Same author

Harnessing Piezoelectric Biomaterials for Pathogenic Eradication and Tissue Regeneration.

Exploration (Beijing, China)·2026
Same author

Erratum to "Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging".

Research (Washington, D.C.)·2026

Related Experiment Video

Updated: Jan 12, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.1K

Engineered immune-driven theranostics for clinical cardiology.

Jing-Ben Zheng1, Xiao-Ye Li1, Ji-Min Zhu2

  • 1Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, 210008, China.

Military Medical Research
|November 4, 2025
PubMed
Summary

Nanotechnology enables precision immunotherapy for cardiovascular diseases (CVDs) by regulating immune responses and imaging cell activity. This approach halts disease progression and prevents further cardiovascular events through personalized interventions.

Keywords:
Cardiovascular diseasesImmune therapyInflammatory regulationMedical imagingNanotheranostics

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.8K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

879

Related Experiment Videos

Last Updated: Jan 12, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

12.1K
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.8K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

879

Area of Science:

  • Cardiovascular Diseases
  • Immunotherapy
  • Nanotechnology
  • Precision Medicine

Background:

  • Cardiovascular diseases (CVDs) involve complex immune-inflammatory responses.
  • Effective management requires integrated strategies for localized and systemic disease.
  • Immune cell activity plays a critical role in CVD pathogenesis.

Purpose of the Study:

  • To review advances in nanomaterial-based immunomodulation for CVDs.
  • To explore nanoplatforms for regulating and imaging immune cells in cardiovascular lesions.
  • To highlight the potential of nanotheranostics in precision cardiovascular medicine.

Main Methods:

  • Summarizing recent research on nanomaterial-based immunomodulation strategies.
  • Discussing mechanisms of immune regulation and enhanced imaging by nanoplatforms.
  • Reviewing therapeutic applications in atherosclerosis, myocardial infarction, stroke, aneurysm, and myocarditis.

Main Results:

  • Nanotechnology-based theranostic platforms offer dual regulation and imaging of immune cells.
  • These systems can halt disease progression at pathological sites.
  • Dynamic visualization facilitates adaptive, personalized therapeutic interventions.

Conclusions:

  • Integrated nanotheranostic paradigms are crucial for next-generation cardiovascular precision medicine.
  • Nanomaterials provide a robust foundation for modulating immune responses in CVDs.
  • This approach promises reduced secondary cardiovascular events and improved patient outcomes.